Lisa LaVange, director of the Office of Biostatistics in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration, has been elected the 113th president of the ASA. LaVange will serve a one-year term as president-elect beginning January 1, 2017. Her term as president becomes effective January 1, 2018. The ASA membership also elected G. David Williamson, senior science adviser at the U.S. Centers for Disease Control and Prevention, as an ASA vice president.
Members also elected several new board members, plus officers for each of the ASA’s 27 sections.
Views and information from the writers of the Amstat News columns: Master’s Notebook, Science Policy, and Funding Opportunities
The latest information and news from the ASA’s education, meetings, and international departments.